Clinicians need to be mindful that certain treatments might be counterproductive and counsel patients about gentle skin care and to use sunscreen daily.
By the year 2050, the US Census Bureau estimates that 50% of the population will comprise people of color; yet, nearly 50% of dermatology residents and dermatologists have indicated that they received inadequate training on skin conditions in this population.
Recent studies suggest that with some caveats, patients with Fitzpatrick skin types IV to VI can achieve satisfactory results without serious adverse effects.
The investigators sought to determine the frequency of complications and adverse effects linked to the use of superficial chemical peels in patients with skin types III to VI.
Compared with baseline, significant reductions in noninflammatory, inflammatory, and total lesions were seen in the first 4 weeks of treatment with CL-BP 3.75%.